Send the following on WhatsApp
Continue to ChatMirati 旗下 Adagrasib 聯合治療獲突破創新資格,用於晚期大腸直腸癌 https://geneonline.news/mirati-adagrasib-crc/?variant=zh-cn
Mirati 旗下 Adagrasib 聯合治療獲突破創新資格,用於晚期大腸直腸癌 https://geneonline.news/mirati-adagrasib-crc/?variant=zh-cn